The bone morphogenetic protein (BMP) ligands inhibit HF fate by suppressing Edar expression in the epidermis, and treatment with Noggin, an antagonist of BMP, leads to a higher density of HF placodes [12]. Here, NOG is linked to hydrops fetalis.